Patents by Inventor Futoshi Okada

Futoshi Okada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9327356
    Abstract: A tooth flank machining device includes a helical teeth grinding wheel, a position adjusting unit] capable of moving a relative position of a rotational axis of the helical teeth grinding wheel to a rotational axis of a work gear, and a controlling unit having a relative position controller activating the position adjusting unit to adjust the relative position of the rotational axis of the helical teeth grinding wheel to the rotational axis of the work gear so that the helical teeth grinding wheel engages the work gear with a grinding wheel tooth flank of the helical teeth grinding wheel abutting on only one of work tooth flanks forming a tooth of the work gear, a grinding wheel rotating unit controller activating a grinding wheel rotating unit, and a torque controlling unit controller activating a rotational torque controlling unit to adjust rotational torque within a predetermined range.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: May 3, 2016
    Assignees: AISIN AI CO., LTD, AI MACHINE TECH CO., LTD.
    Inventors: Fumio Nakagawa, Kazuhiko Muramatsu, Daisuke Tanaka, Takaaki Kato, Futoshi Okada, Hiromasa Tsuji
  • Patent number: 9212210
    Abstract: The present invention is to provide a polypeptide specifically inhibiting the activity of Akt (Protein Kinase B), the DNA thereof, the antibody thereof, an inhibitor of Akt activity or an antitumor agent, and the like. The polypeptide comprises polypeptides (SEQ ID NO: 1, 3, 5, 7, and 9 of the sequence listing) that contain an amino acid sequence corresponding to any of the position of amino acid residue 10-24 of human TCL1, amino acid residue 8-22 of human TCL1B, amino acid residue 5-19 of human MTCP1, and amino acid residue 9-24 of mouse or rat TCL1; and the derivatives. Further, the present invention includes DNA encoding the polypeptide (SEQ ID NO: 2, 4, 6, 8 or 10 of the sequence listing), and the antibodies specifically binding to the polypeptides. The polypeptide of the present invention can be used for an inhibitor of Akt activity, an antitumor agent, or the like.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: December 15, 2015
    Assignee: Japan Science and Technology Agency
    Inventors: Masayuki Noguchi, Futoshi Okada, Makoto Hiromura
  • Publication number: 20150118938
    Abstract: A tooth flank machining device includes a helical teeth grinding wheel, a position adjusting unit] capable of moving a relative position of a rotational axis of the helical teeth grinding wheel to a rotational axis of a work gear, and a controlling unit having a relative position controller activating the position adjusting unit to adjust the relative position of the rotational axis of the helical teeth grinding wheel to the rotational axis of the work gear so that the helical teeth grinding wheel engages the work gear with a grinding wheel tooth flank of the helical teeth grinding wheel abutting on only one of work tooth flanks forming a tooth of the work gear, a grinding wheel rotating unit controller activating a grinding wheel rotating unit, and a torque controlling unit controller activating a rotational torque controlling unit to adjust rotational torque within a predetermined range.
    Type: Application
    Filed: October 25, 2012
    Publication date: April 30, 2015
    Applicant: AISIN AI CO., LTD.
    Inventors: Fumio Nakagawa, Kazuhiko Muramatsu, Daisuke Tanaka, Takaaki Kato, Futoshi Okada, Hiromasa Tsuji
  • Patent number: 8440630
    Abstract: The present invention is to provide a polypeptide specifically inhibiting the activity of Akt (Protein Kinase B), the DNA thereof, the antibody thereof, an inhibitor of Akt activity or an antitumor agent, and the like. The polypeptide comprises polypeptides (SEQ ID NO: 1, 3, 5, 7, and 9 of the sequence listing) that contain an amino acid sequence corresponding to any of the position of amino acid residue 10-24 of human TCL1, amino acid residue 8-22 of human TCL1B, amino acid residue 5-19 of human MTCP1, and amino acid residue 9-24 of mouse or rat TCL1; and the derivatives. Further, the present invention includes DNA encording the polypeptide (SEQ ID NO: 2, 4, 6, 8 or 10 of the sequence listing), and the antibodies specifically binding to the polypeptides. The polypeptide of the present invention can be used for an inhibitor of Akt activity, an antitumor agent, or the like.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: May 14, 2013
    Assignee: Japan Science and Technology Agency
    Inventors: Masayuki Noguchi, Futoshi Okada, Makoto Hiromura
  • Publication number: 20120034651
    Abstract: The present invention is to provide a polypeptide specifically inhibiting the activity of Akt (Protein Kinase B), the DNA thereof, the antibody thereof, an inhibitor of Akt activity or an antitumor agent, and the like. The polypeptide comprises polypeptides (SEQ ID NO: 1, 3, 5, 7, and 9 of the sequence listing) that contain an amino acid sequence corresponding to any of the position of amino acid residue 10-24 of human TCL1, amino acid residue 8-22 of human TCL1B, amino acid residue 5-19 of human MTCP1, and amino acid residue 9-24 of mouse or rat TCL1; and the derivatives. Further, the present invention includes DNA encording the polypeptide (SEQ ID NO: 2, 4, 6, 8 or 10 of the sequence listing), and the antibodies specifically binding to the polypeptides. The polypeptide of the present invention can be used for an inhibitor of Akt activity, an antitumor agent, or the like.
    Type: Application
    Filed: December 14, 2004
    Publication date: February 9, 2012
    Inventors: Masayuki Noguchi, Futoshi Okada, Makoto Hiromura
  • Patent number: 7150870
    Abstract: The invention prevents or treats a tumor, inhibiting tumor growth and malignant progression by providing an antitumor agent containing a treated SOD as the active ingredient, especially a melon SOD coated with gliadin. The invention also applies to a method of preventing or treating the tumor.
    Type: Grant
    Filed: September 4, 2003
    Date of Patent: December 19, 2006
    Assignees: Asama Chemical Co., Ltd., Combi Corporation
    Inventors: Futoshi Okada, Masuo Hosokawa, Hiroshi Shionoya
  • Publication number: 20040105851
    Abstract: The invention prevents or treats tumor, inhibiting tumor growth and malignant progression by providing an antitumor agent comprising a treated SOD as the active ingredient, especially a melon SOD coated with gliadin. The invention also applies to a method of preventing or treating tumor.
    Type: Application
    Filed: September 4, 2003
    Publication date: June 3, 2004
    Inventors: Futoshi Okada, Masuo Hosokawa, Hiroshi Shionoya